The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers
Karen S. Anderson(Mayo Clinic in Arizona), Beth Overmoyer(Boston University)
Cited by 23
Related Papers
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
|Nature Communications|2019|194
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
|British Journal of Cancer|2011|69